TECHNOLOGY DRIVEN COMPANY IN RESPIRATORY CARE
MEK-ICS will lead the changes in respiratory care
through continuous innovation.
MEK-ICS will lead the changes in respiratory care
through continuous innovation.
TECHNOLOGY DRIVEN COMPANY IN RESPIRATORY CARE
Internalizing 5 key technologies
in the respiratory care
Internalizing 5 key technologies
in the respiratory care
TECHNOLOGY DRIVEN COMPANY IN RESPIRATORY CARE
Securing product lineups needed for
all areas of respiratory care
Securing product lineups needed for
all areas of respiratory care
OVERVIEW
MEK-ICS has taken the lead of developing and commercializing
ventilators
based on Korea’s first and unique respiratory technologies.
We are proactive in expanding the application of our respiratory care solutions developed by various research activities in order to help more patients.
This effort will allow us to expand our top-notch technologies to both hospital and homecare sectors with the presentation of various evidences on how the demographic and environmental changes have effects on respiration and health of the mankind.
MEK-ICS has a strong belief that product safety and quality of raw materials must in no way be compromised.
To this end, we have established internal systems and R&D bases satisfying the quality and safety standards for the functionality of respiratory care products. Those help us correctively understand overseas local market circumstances and build a technologically cooperative agent system, thereby contributing to MEK-ICS evolving into a global player in the respiration care market.

ACHIEVEMENTS

Certification of CE, ISO etc. through continuous R&D of MEK

보건복지부 인증 혁신형 의료기기기업 K-INNO MEDTECH
KOSDAQ Listed Companies association
식품의약품안전처
글로벌 강소기업, Small Giant Company of Korea
ISO 13485, Internation organization for standardization
의료기기 제조 및 품질관리기준, GMP, Ministry of food and drug safety
CE 인증마크
INVESTORS
We will contribute to improving the quality of human life through technologies and services for healthy respiration.
  • Change 1,300
  • % Change -3.76%
  • (As of 2021/01/15 18:59)
  • 33,300
  • KOSPI 3,085.90
  • KOSDAQ 964.44
Disclosure information We provide you with our disclosure information.
COVID-19